The drugmaker highlighted in today’s article may be one of the best stocks to buy for both July and the third quarter, if history is any indication. Why? Over the last 10 years, the stock in question has ended July higher 100% of the time (with an average gain of 10.68%) and has ended the third quarter higher 90% of the time (with an average gain of 13.63%). For the stock in question and how traders may want to go about exploiting this historical trend – as well as more top S&P 500 stocks in July and the third quarter – CLICK HERE.